Victor Bulto is Head, US Pharmaceuticals. In this role, he leads the US Pharmaceuticals business including the expected upcoming launches of new, transformative medicines in the US. He serves on the US Country Leadership Team and on the Global Pharmaceutical Executive Team.
Most recently Victor led the US Immunology, Hepatology & Dermatology business, overseeing the company’s number one selling medicine in the US, Cosentyx. Previously he served as Head of the US Alcon Pharmaceuticals business and Head of Neuroscience in Europe. Prior to joining Novartis, Victor was a medical device sales representative.
Victor holds an M.B.A. from ESADE Business School in Spain, a master’s degree in health economics and pharmacoeconomics and a post-graduate degree in pharmaceutical marketing from Pompeu Fabra University in Spain. He also completed the Advanced Management Program at Harvard Business School. In addition, he holds a B.S. in chemistry and a master’s in chemical engineering, both from Ramon Llull University in Spain.